Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-17-019679

VP of Sales & Marketing bought 55,000 shares at an average $0.50 ($27,374)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +19,609 $0.50 $9,805 19,609 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +6,965 $0.50 $3,483 26,574 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +10,600 $0.50 $5,300 37,174 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +700 $0.50 $350 37,874 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +1,400 $0.50 $700 39,274 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +126 $0.47 $59 39,400 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +500 $0.47 $235 39,900 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +200 $0.46 $92 40,100 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +10,160 $0.50 $5,080 50,260 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +300 $0.47 $141 50,560 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +40 $0.49 $20 50,600 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +200 $0.48 $96 50,800 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +200 $0.47 $94 51,000 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +100 $0.48 $48 51,100 D
Krachon Michael VP of Sales & Marketing 2017-11-20 Purchase +3,900 $0.48 $1,872 55,000 D
Open-market purchases · 55,000 sh · avg $0.50 · $27,374
Loading xslF345X03/rdgdoc.xml…